Research and Markets: Disease and Therapy Review: Eczema

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/thjp9l/disease_and) has announced the addition of the "Disease and Therapy Review: Eczema" report to their offering.

The Eczema Disease and Therapy Review provides an overview of eczema, with prevalence numbers (pediatric and total), percentages and trends for major countries worldwide, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the eczema market, as well as sales of leading drugs and therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the authors' senior market research team of. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.

The data contained in these reports comes from key industry secondary data sources, such as the authors Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

Key Topics Covered:

I. OVERVIEW

II. PREVALENCE

III. DIAGNOSIS

IV. TREATMENT

View original post here:
Research and Markets: Disease and Therapy Review: Eczema